NewAmsterdam Pharma Balance Sheet (2021-2026) | NAMS

Balance Sheet Dec2021 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 60.74M447.40M441.31M416.71M368.31M340.45M481.15M430.71M422.73M771.74M748.42M563.86M538.41M490.00M457.61M
Receivables - Other (Quarter) 0.82M0.88M3.98M2.13M1.65M1.75M1.44M3.29M3.90M6.76M8.02M
Prepaid Assets (Quarter) 1.71M7.83M6.28M2.12M2.12M2.24M15.14M2.21M8.83M1.46M28.07M38.14M2.27M
Current Assets (Quarter) 67.35M457.21M423.88M346.79M487.82M445.35M437.87M863.41M817.30M769.85M732.33M675.70M658.04M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.22M0.15M121.960.05M0.10M0.23M0.23M0.24M0.24M0.31M0.32M0.38M0.38M
Long-Term Investments (Quarter) 44.17M53.09M92.61M71.24M
Intangibles (Quarter) 84.84M0.09M
Goodwill & Intangibles (Quarter) 84.84M0.09M0.17M0.49M0.54M0.59M0.53M0.50M0.47M0.44M0.41M0.38M
Other Non-Current Assets (Quarter) 148.96101.270.04M0.02M0.01M2.58M
Non-Current Assets (Quarter) 1.04M85.14M0.09M0.31M0.64M1.34M1.32M1.21M1.11M45.26M54.10M93.58M74.60M
Assets (Quarter) 68.39M542.35M512.99M347.10M488.46M446.69M439.19M864.62M818.41M815.11M786.43M769.28M732.64M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 11.24M18.88M22.71M11.40M9.97M5.28M7.04M4.74M8.02M5.89M10.10M8.97M8.09M
Payables (Quarter) 11.24M18.88M22.71M11.40M9.97M5.28M7.04M4.74M8.02M5.89M10.10M8.97M8.09M
Accumulated Expenses (Quarter) 2.00M3.38M1.10M2.32M4.19M8.72M1.97M3.78M5.87M9.36M2.27M
Short term Debt (Quarter) 3.97M0.01M12.57M33.06M23.55M18.90M37.51M23.52M20.93M44.36M57.27M50.23M
Current Leases (Quarter) 0.06M0.06M0.06M0.04M0.23M0.24M0.25M0.25M0.23M0.18M0.14M0.02M
Current Deferred Revenue (Quarter) 18.67M9.96M8.12M6.06M4.50M6.01M3.03M3.99M3.99M
Total Current Liabilities (Quarter) 11.30M36.18M0.04M49.90M59.73M45.31M41.26M106.92M40.91M36.51M58.27M85.79M67.42M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter) 4.58M10.55M1.02M0.44M0.22M
Operating Leases (Quarter) 0.13M0.06M0.07M0.33M0.27M0.20M0.14M0.10M0.09M0.07M
Other Non-Current Liabilities (Quarter) 7.20M0.01M7.79M16.49M13.39M18.81M
Total Non-Current Liabilities (Quarter) 0.13M11.84M11.43M50.92M60.17M45.86M41.52M
Total Liabilities (Quarter) 11.43M48.01M-398.41M512.53M-331.83M58.70M76.66M59.25M60.33M107.12M41.05M36.62M58.36M85.85M67.42M
Shareholder's Equity
Total Debt (Quarter) 3.97M0.01M12.57M33.06M23.55M18.90M37.51M23.52M20.93M44.36M57.27M50.23M
Common Equity (Quarter) 56.96M494.33M398.41M373.34M331.83M288.39M411.80M387.44M378.86M757.50M777.36M778.50M728.07M683.43M665.22M
Shareholder's Equity (Quarter) 56.96M494.33M398.41M373.34M331.83M288.39M411.80M387.44M378.86M757.50M777.36M778.50M728.07M683.43M665.22M
Liabilities and Shareholders Equity (Quarter) 68.39M542.35M512.99M347.10M488.46M446.69M439.19M864.62M818.41M815.11M786.43M769.28M732.64M
Retained Earnings (Quarter) -39.67M4.79M-211.76M4.42M-410.74M-449.75M4.42M-558.57M4.43M4.33M-687.47M-762.39M-810.83M
Treasury Shares (Quarter) 0.62M0.61M0.61M0.61M0.61M0.14M0.66M0.72M0.72M0.73M1.01M
Shares Outstanding (Quarter) 6.05M83.21M81.77M82.32M82.47M82.47M89.72M90.02M92.17M108.06M112.17M112.51M113.17M114.40M116.64M